Successful Milestone in Lead Discovery Collaboration with Nerviano Medical Sciences

03-Mar-2009 - USA

ChemDiv, Inc. announced that it has earned the successful milestone in its lead discovery collaboration with Nerviano Medical Sciences (NMS). In October 2007, ChemDiv and NMS expanded their partnership to discover and develop potential anticancer agents. Under the terms of the collaboration, ChemDiv will receive a milestone payment for successful delivery of a lead molecule to NMS, in addition to research fees earned for discovery services.

Nikolay Savchuk, President and CEO of ChemDiv, Inc. commented: “We are very pleased to be able to deliver high value to Nerviano's oncology program applying our Discovery outSource SM platforms. ChemDiv's rational approach to small molecule discovery and strengths in medicinal chemistry and pre-clinical biology will help to secure further success in this collaboration. Once again, ChemDiv’s leadership in discovery and development services has been validated through our work with Nerviano, one of Europe’s largest oncology-focused developers.”

Other news from the department business & finance

Most read news

More news from our other portals

Fighting cancer: latest developments and advances